Mark M Painter
Overview
Explore the profile of Mark M Painter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
2040
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Proal A, Aleman S, Bomsel M, Brodin P, Buggert M, Cherry S, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39947217
There are no approved treatments for post-COVID-19 condition (also known as long COVID), a debilitating disease state following SARS-CoV-2 infection that is estimated to affect tens of millions of people....
2.
Chen J, Ionita M, Feng Y, Lu Y, Orzechowski P, Garai S, et al.
Nat Commun
. 2025 Feb;
16(1):1576.
PMID: 39939580
Recent advances in cytometry have enabled high-throughput data collection with multiple single-cell protein expression measurements. The significant biological and technical variance in cytometry has posed a formidable challenge during the...
3.
Gomez-Rivera F, Terry V, Chen C, Painter M, Virgilio M, Yaple-Maresh M, et al.
JCI Insight
. 2024 Dec;
10(2).
PMID: 39636695
Despite effective treatment, human immunodeficiency virus (HIV) persists in optimally treated people as a transcriptionally silent provirus. Latently infected cells evade the immune system and the harmful effects of the...
4.
Kim J, Ionita M, Lee M, McKeague M, Pattekar A, Painter M, et al.
Cell Rep Med
. 2024 Nov;
5(11):101808.
PMID: 39515318
Single-cell cytometry data are crucial for understanding the role of the immune system in diseases and responses to treatment. However, traditional methods for annotating cytometry data face challenges in scalability,...
5.
Chen J, Ionita M, Feng Y, Lu Y, Orzechowski P, Garai S, et al.
bioRxiv
. 2024 May;
PMID: 38766268
Recent advances in cytometry technology have enabled high-throughput data collection with multiple single-cell protein expression measurements. The significant biological and technical variance between samples in cytometry has long posed a...
6.
Johnston T, Li S, Painter M, Atkinson R, Douek N, Reeg D, et al.
Immunity
. 2024 Mar;
57(4):912-925.e4.
PMID: 38490198
The spike glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) continues to accumulate substitutions, leading to breakthrough infections of vaccinated individuals. It remains unclear if exposures to antigenically distant SARS-CoV-2...
7.
McCauley M, Huston M, Condren A, Pereira F, Cline J, Yaple-Maresh M, et al.
J Med Chem
. 2024 Mar;
67(6):4483-4495.
PMID: 38452116
The human immunodeficiency virus (HIV)-encoded accessory protein Nef enhances pathogenicity by reducing major histocompatibility complex I (MHC-I) cell surface expression, protecting HIV-infected cells from immune recognition. Nef-dependent downmodulation of MHC-I...
8.
Johnston T, Li S, Painter M, Atkinson R, Douek N, Reeg D, et al.
medRxiv
. 2024 Jan;
PMID: 38260304
The spike glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) continues to accumulate substitutions, leading to breakthrough infections of vaccinated individuals and prompting the development of updated booster vaccines. Here,...
9.
Painter M, Johnston T, Lundgreen K, Santos J, Qin J, Goel R, et al.
Nat Immunol
. 2023 Sep;
24(10):1711-1724.
PMID: 37735592
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of vaccinated individuals is increasingly common but rarely results in severe disease, likely due to the enhanced potency and accelerated kinetics of...
10.
Proal A, VanElzakker M, Aleman S, Bach K, Boribong B, Buggert M, et al.
Nat Immunol
. 2023 Sep;
24(10):1778.
PMID: 37723351
No abstract available.